SCHEMBL6946470

SCHEMBL6946470

CC(C)(C)OC(=O)N(CCO)CCNC(=O)C(F)(F)F

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA14 Q9ULX7 2/20 0.76
ALDH1A1 P00352 2/20 0.41
POLB P06746 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
SSTR4 P31391 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
EPHX1 P07099 1/20 0.38
CA3 P07451 2/20 0.37
CA5A P35218 2/20 0.37
CA5B Q9Y2D0 2/20 0.37
CA12 O43570 1/20 0.37
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37
CA6 P23280 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
MTNR1A P48039 2/20 0.31
MTNR1B P49286 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5464993 0.94 CA14 (0.80) CA14ALDH1A1POLBSMN1; SMN2SSTR4
SCHEMBL10231797 0.92 CA14 (0.78) CA14ALDH1A1POLBSMN1; SMN2SSTR4
SCHEMBL25932928 0.88 CA14 (0.72) CA14ALDH1A1POLBSMN1; SMN2SSTR4
SCHEMBL20067626 0.88 CA14 (0.67) CA14ALDH1A1POLBSMN1; SMN2SSTR4
SCHEMBL10232583 0.87 CA14 (0.70) CA14ALDH1A1POLBSMN1; SMN2SSTR4
SCHEMBL12201127 0.87 CA14 (0.70) CA14ALDH1A1POLBSMN1; SMN2MEN1
SCHEMBL24215034 0.87 CA14 (0.69) CA14ALDH1A1POLBSMN1; SMN2MEN1
SCHEMBL1274571 0.87 CA14 (1.00) CA14ALDH1A1POLBSMN1; SMN2SSTR4
SCHEMBL6753294 0.83 TDP1 (0.54) CA14ALDH1A1SSTR4MEN1KMT2A
SCHEMBL3486833 0.82 CA14 (0.89) CA14ALDH1A1POLBSMN1; SMN2SSTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022117051-A1 MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 北京鞍石生物科技有限责任公司 2022-06-09 WO disclosed
WO-2022117051-A1 MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 北京鞍石生物科技有限责任公司 2022-06-09 WO disclosed
CN-114057771-A Macrocyclic compound and preparation method and application thereof 北京鞍石生物科技有限责任公司 2022-02-18 CN disclosed
US-20030207919-A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use NICOX S.A. (FR) 2003-11-06 US disclosed
US-6593347-B2 Especially a nitrosated and/or nitrosylated arylpropionic acid, arylacetic acid, enolic anilide or an oxicam NITROMED, INC. 2003-07-15 US disclosed
US-20020016322-A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositons and methods of use NICOX S.A. (FR) 2002-02-07 US disclosed
US-6297260-B1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use NITROMED, INC. 2001-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020016322-A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositons and methods of use NOS2, NOS3, NOS1 CA14 1147/4885ALDH1A1 1076/4885POLB 3012/4885
US-20030207919-A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use NOS2, NOS1, NOS3 CA14 2679/4885ALDH1A1 360/4885POLB 4189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.